Lataa...

Sitagliptin ameliorates high glucose-induced cell proliferation and expression of the extracellular matrix in glomerular mesangial cells

Diabetic nephropathy (DN) is one of the most important causes that leads to end-stage renal disease and the efficacy of strategies currently available for the prevention of DN remains unsatisfactory. Sitagliptin (SIT), which is a dipeptidyl peptidase-4 inhibitor, exhibited a modest beneficial effect...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Exp Ther Med
Päätekijät: Zhang, Guan-Ying, Wang, Dong-Dong, Cao, Zheng, Wei, Tong, Liu, Chen-Xu, Wei, Qun-Li
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2017
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5639317/
https://ncbi.nlm.nih.gov/pubmed/29042993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.5002
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!